Second-Line Treatment of Advanced Urothelial Cancer with Paclitaxel and Everolimus in a German Phase II Trial (AUO Trial AB 35/09)

Publisher： Karger

E-ISSN： 1423-0232|89|2|70-78

ISSN： 0030-2414

Source： Oncology, Vol.89, Iss.2, 2015-03, pp. : 70-78

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Second-Line Treatment of Advanced Colorectal Cancer with a Weekly Simultaneous 24-Hour Infusion of 5-Fluorouracil and Sodium-Folinate: A Multicentre Phase II Trial

By  

Oncology Research and Treatment, Vol. 27, Iss. 5, 2004-10 ,pp. : 449-454

Karger

Access to resources Recommend Favorite

A phase II trial of second‐line axitinib following prior antiangiogenic therapy in advanced hepatocellular carcinoma

By  

CANCER, Vol. 121, Iss. 10, 2015-05 ,pp. : 1620-1627

John Wiley & Sons Inc

Access to resources Recommend Favorite

Phase 2 Trial of Interferon-Beta as Second-Line Treatment of Ovarian Cancer, Fallopian Tube Cancer, or Primary Carcinoma of the Peritoneum

By  

Oncology, Vol. 66, Iss. 5, 2004-09 ,pp. : 343-346

Karger

Access to resources Recommend Favorite

Larotaxel with Cisplatin in the First-Line Treatment of Locally Advanced/Metastatic Urothelial Tract or Bladder Cancer: A Randomized, Active-Controlled, Phase III Trial (CILAB)

By  

Oncology, Vol. 85, Iss. 4, 2013-09 ,pp. : 208-215

Karger

Access to resources Recommend Favorite

Imatinib Mesylate for Palliative Second-Line Treatment of Advanced Biliary Tract Cancer: A Bicentric Phase II Study

By  

Oncology Research and Treatment, Vol. 34, Iss. 8-9, 2011-08 ,pp. : 469-470

Karger

Access to resources Recommend Favorite